Lifeway Food Stock Price, News & Analysis

Lifeway Foods (Nasdaq: LWAY), a leading U.S. kefir and fermented probiotic products supplier, has partnered with Erewhon Market to launch their second collaborative drink - the Love Your Gut Pumpkin Spice Smoothie. Available exclusively during October 2025, this limited-edition smoothie features Lifeway Organic Plain Kefir combined with seasonal ingredients including pumpkin puree, dates, pumpkin spice, cinnamon, banana, cold brew, and dairy cream.

The smoothie incorporates Lifeway's Organic Plain Kefir, which contains 12 live and active probiotic cultures, protein, and calcium, designed to support immune system function and promote a balanced microbiome. The beverage will be available at all Erewhon Market locations throughout October.

Lifeway Foods (NASDAQ: LWAY) has announced a significant Cooperation Agreement with Danone North America PBC. The agreement includes major corporate governance changes, with four new independent directors to be appointed by November 14, 2025, and the separation of Chair and CEO roles by October 30, 2025.

Key elements include the stay of pending litigation regarding Danone's Stockholders' Agreement, Danone's commitment not to support the Smolyansky family's consent solicitation, and a planned board refreshment process. The agreement also allows for equity-based compensation issuance and includes provisions for Danone's potential share registration through a shelf registration statement by October 30, 2025.

Lifeway Foods (Nasdaq: LWAY), a leading U.S. kefir and fermented probiotic products supplier, has responded to Danone's withdrawal of its acquisition proposal. The company reaffirmed its commitment to executing its strategic plan independently.

Lifeway reported strong performance metrics, including record Q2 2025 net sales of $53.9 million, representing an 18% year-over-year increase. The company's momentum continued into Q3, with unaudited net sales of $39.1 million in the first two months, showing a 20% year-over-year growth. Notably, Lifeway has achieved 22 consecutive quarters of growth.

Lifeway Foods (Nasdaq: LWAY), America's leading kefir producer, has announced significant expansion progress at its Waukesha, Wisconsin facility. The company has completed stage one of a multi-million dollar expansion project that will double production capacity when fully operational in Q3 2026.

The company reported impressive financial results, including record Q2 2025 net sales of $53.9 million (18% YoY growth) and strong Q3 performance with $39.1 million in unaudited net sales for July-August (20% YoY increase). Lifeway has achieved 22 consecutive quarters of growth and commands over 90% of the U.S. kefir market, with distribution across multiple countries.

Lifeway Foods (Nasdaq: LWAY) has announced the launch of Muscle Mates™, a new functional beverage combining 20g protein, 5g creatine, and 12 probiotic cultures. The product aims to disrupt the fitness nutrition category with its triple-benefit formula supporting muscle building, strength, and gut health.

Set to launch nationwide by Q4 2025, Muscle Mates™ will be available in Mixed Berry, Strawberry Banana, and Vanilla flavors. The product launch aligns with significant market growth, as the global creatine supplements market reached $1.11 billion in 2024, with creatine sales surging 300% at The Vitamin Shoppe from 2019 to 2024.

Lifeway Foods (Nasdaq: LWAY), the leading U.S. kefir producer, reported estimated unaudited net sales of $39.1 million for the first two months of Q3 2025 through August 31. This represents a 20% year-over-year increase, driven by strong demand for Lifeway Kefir and the high-protein Lifeway Farmer Cheese line.

The company's early Q3 announcement highlights record-setting revenue performance, demonstrating continued category dominance in the probiotic food sector. CEO Julie Smolyansky attributes the growth to successful innovation, marketing, and execution strategies, positioning Lifeway for continued expansion in the functional foods market.

Lifeway Foods (NASDAQ: LWAY) has announced the relaunch of its Basics Plus™ line of kefir and colostrum supplement shots, reviving a pioneering product from the late 1990s. The innovative beverage combines Lifeway's probiotic kefir with colostrum in a 3.5oz grab-and-go format, targeting both digestive and immune health support.

Originally introduced as America's first milk-based dietary supplement in grocery dairy cases, the product was ahead of its time. CEO Julie Smolyansky sees an opportunity to offer a higher-quality alternative to current probiotic shots, which often contain water, brown rice powder, and sugar. The relaunch comes as the global probiotic market is projected to reach $200 billion by 2030, with both kefir and colostrum experiencing significant growth in the health and wellness sector.

Lifeway Foods (NASDAQ: LWAY) has announced the expansion of its ProBugs® kefir line with new conventional whole milk pouches in three flavors. The products will be available nationwide in Creamy Orange, Goo-Berry, and Strawnana varieties. This launch follows the success of ProBugs' original 2007 debut as the first-ever pouched probiotic kefir for kids in the U.S.

The expansion aligns with strong market growth, as the global kids' yogurt pouch market reached USD 3.2 billion in 2024 and is projected to grow at a 6.1% CAGR to reach USD 5.47 billion by 2033. The new products aim to make gut health more accessible while maintaining the brand's signature probiotic benefits, protein content, and calcium in a convenient, kid-friendly format.

Lifeway Foods (Nasdaq: LWAY) reported exceptional Q2 2025 results with record net sales of $53.9 million, representing an 18% volume-led increase on a comparable basis. The company achieved significant milestones including gross margin expansion of 160 basis points year-over-year to 28.6% and net income of $4.2 million ($0.28 per share).

The momentum continues into Q3 2025, with unaudited net sales reaching $26.4 million through August 11, up over 20% year-over-year. July marked a historic achievement with the highest weekly sales ever recorded, exceeding $5.5 million. The company maintains its long-term target of $45-$50 million in Adjusted EBITDA for FY 2027.